Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Ind-Swift Laboratories Limited

Market Cap 11.4B 121M 105M 97.12M 91.36M 171M 172M 1.16B 449M 5.62B 454M 444M 19.47B P/E 2024
1.41x
P/E 2025 2.38x
Enterprise Value 7.13B 75.66M 65.93M 60.77M 57.16M 107M 108M 723M 281M 3.51B 284M 278M 12.18B EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.56%
Yield 2024 *
-
Yield 2025 -
1 day+0.56%
1 week+4.02%
Current month+11.52%
1 month+26.03%
3 months+19.21%
6 months+81.27%
Current year+92.14%
1 week 158.3
Extreme 158.3
170.8
1 month 129.5
Extreme 129.5
173.5
Current year 88.5
Extreme 88.5
173.5
1 year 87
Extreme 87
173.5
3 years 67.15
Extreme 67.15
186
5 years 51.1
Extreme 51.1
186
10 years 15.25
Extreme 15.25
186
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 43 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+4.02% - - 149M
+0.24%+1.71%+10.73%+83.95% 46.28B
-3.14%+2.94%+49.76%+90.77% 34.73B
+0.35%-2.01%-9.52%+34.73% 11.56B
+1.22%-2.85%+12.12%+94.97% 11.32B
-0.57%+2.14%+38.16%+129.26% 9.27B
-1.02%+0.26%+12.20%+39.05% 7.13B
-1.98%+0.93%+42.77%-18.84% 6.6B
+0.81%+0.44%+29.73%+235.28% 6.39B
+0.73%-2.44%-37.77%-7.15% 4.98B
Average -0.27%-0.19%+16.46%+75.78% 15.36B
Weighted average by Cap. -0.67%+0.94%+21.53%+81.98%

Financials

2024 2025
Net sales 12.97B 138M 120M 111M 104M 195M 196M 1.32B 511M 6.39B 517M 506M 22.16B 5.62B 59.6M 51.93M 47.87M 45.03M 84.24M 84.83M 570M 221M 2.77B 224M 219M 9.59B
Net income 4.21B 44.67M 38.92M 35.88M 33.74M 63.13M 63.57M 427M 166M 2.07B 168M 164M 7.19B 2.5B 26.58M 23.16M 21.35M 20.08M 37.56M 37.83M 254M 98.63M 1.23B 99.76M 97.62M 4.28B
Net Debt -4.15B -44.07M -38.39M -35.39M -33.29M -62.28M -62.72M -421M -164M -2.05B -165M -162M -7.09B -4.27B -45.26M -39.43M -36.35M -34.19M -63.97M -64.42M -432M -168M -2.1B -170M -166M -7.29B
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
19/06/26 169.45 +0.56% 400
18/06/26 168.50 +3.69% 114,686
17/06/26 162.50 -0.21% 33,940
16/06/26 162.85 +0.68% 37,697
15/06/26 161.75 -0.71% 47,632
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!